生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Bentamapimod (AS 602801) induces cell death in a dose-dependent manner across various cancer cell lines including human pancreatic, non-small cell lung, ovarian cancer, and glioblastoma cells, without affecting the viability of normal human fibroblasts. It also hinders the self-renewal and tumor-initiating capabilities of cancer stem cells that survive treatment with Bentamapimod (AS 602801)[2]. | ||
作用机制 | AS-602801 is an ATP competitive JNK inhibitor.[1] |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.19mL 0.44mL 0.22mL |
10.93mL 2.19mL 1.09mL |
21.86mL 4.37mL 2.19mL |
参考文献 |
---|
[1]Zhao J, Pei G. Evoking plasmin for beta-amyloid clearance. Cell Res. 2008 Aug;18(8):803-4. |